The Future of UK MedTech Regulation and Access – webinar available
Significant changes and a revised UK MedTech regulatory framework have resulted from the UK leaving the EU in January 2021.
A recent ‘Medical Alley Association’ moderated webinar brings the latest views and insights on the Future of UK MedTech Regulation and Access, with a 1-hour Q&A direct from the UK medtech regulator – the MHRA.
Intended to accelerate the pace of access to the best new technologies, the key changes discussed in the webinar recording include:
- Implications for manufacturers of the new UK regulatory framework
- Digital medical technologies, including the role of NHSX and regulatory views on artificial intelligence and machine learning as a medical device
- NICE’s evolving role in world-leading health technology assessment, and,
- a new MedTech funding mandate linked to positive NICE guidance
The session was opened by British Consul General Alan Gogbashian, followed by a Q&A discussion with Professor Peter Groves, Chairman of the Medicines and Healthcare products Regulatory Agency’s (MHRA) Devices Expert Advisory Committee (DEAC), and Graeme Tunbridge, Director of Devices at the MHRA.
Until March 2021, Professor Peter Groves had also been the Chair of the NICE Medical Technologies Advisory Committee (MTAC), of which D4D’s MedTech Theme Lead, Dr Avril McCarthy, is an active member.
